| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702537 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
The CTLA4 pathway appears to be deregulated along with the PD-1/PD-L1 pathway in bladder carcinogenesis, with good correlation between mRNA and protein expression endorsing the useful role of immune checkpoints, especially for a large subgroup of MIBC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Constance M.D., Diane M.D., Ph.D., Sophie M.D., Mathilde M.D., Ph.D., Nicolas Barry M.D., Ph.D., Anne M.D., Benoit M.D., Ph.D., Marc M.D., Ph.D., Ivan M.D., Ph.D., Géraldine M.D., Ph.D.,